Diseases, Conditions, Syndromes

Merck's COVID pill hailed after cutting hospitalizations by 50%

US pharmaceutical company Merck said Friday it will seek authorization of its oral drug molnupiravir for COVID-19 after it was shown to reduce the chance newly infected patients were hospitalized by 50 percent.

Diseases, Conditions, Syndromes

Pfizer starts large trial for anti-COVID pill

Pfizer said Monday it had begun a middle-to-late stage clinical trial of a pill to stave off COVID in people who are exposed to infection.

Medications

A new oral antiviral drug for COVID is being tested in humans

Despite the effectiveness of vaccines, we still need drugs to treat COVID. Even people who have been double vaccinated stand a small chance of getting COVID and ending up moderately or even severely ill. There are drugs to ...

Medications

Rethinking the antiviral drug Remdesivir

Remdesivir is an antiviral drug originally discovered as part of a program to develop antiviral agents with activity against novel emerging viruses. In the first months of the COVID-19 pandemic, it was tested as a potential ...

page 17 from 40